Efficacy of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma: a Meta-analysis

Introduction Hepatocellular carcinoma is a lethal disease and there has been a debate regarding the first-line treatment of its advanced and unresectable form. Observational studies have explored atezolizumab plus bevacizumab versus lenvatinib, yielding mixed results. This systematic review and meta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastrointestinal cancer 2024-03, Vol.55 (1), p.467-481
Hauptverfasser:	Changez, Mah I Kan, Khan, Maimoona, Uzair, Muhammad, Tahir, Muhammad Fawad, Mohsin, Maryam, Hussain, Amna Faiyaz, Saqib, Vania, Molani, Muhammad Khizer, Ahmed, Aisha Habib, Khalid, Saad
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - administration & dosage Bevacizumab - therapeutic use Cancer Research Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Gastroenterology Humans Internal Medicine Liver Neoplasms - drug therapy Liver Neoplasms - mortality Liver Neoplasms - pathology Medicine Medicine & Public Health Oncology Phenylurea Compounds - administration & dosage Phenylurea Compounds - therapeutic use Quinolines - administration & dosage Quinolines - adverse effects Quinolines - therapeutic use Radiotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!